Nplate Sales: Sales of Nplate® (romiplostim) increased 23 percent to $80 million in the fourth quarter of 2011 versus $65 million in the fourth quarter of 2010. http://wwwext.amgen.com/media/media_pr_detail.jsp?releaseID=1653300